Objective:

To examine the indications, clinical evidence, and practical considerations for managing severe ocular surface disease and inflammatory dry eye using scleral lenses, highlighting their role in improving patient quality of life.

Approach:

Key Findings:

• Scleral lenses provide significant relief from symptoms of dry eye disease and ocular surface disorders.
• They offer customized vision correction that can exceed that of spectacles and soft contact lenses.
• Patients with conditions like Sjögren syndrome show marked improvement in symptoms and quality of life with scleral lens use.

Interpretation:

Scleral lenses are a valuable therapeutic option for patients with severe ocular surface disease, particularly when conventional treatments are ineffective.

Limitations:

• The article does not provide specific data on long-term outcomes of scleral lens use, particularly regarding symptom recurrence and lens-related complications.
• Further research is needed to establish standardized fitting and management protocols, especially for diverse patient populations.

Conclusion:

Scleral lenses represent an important advancement in the management of ocular surface diseases, offering significant relief and improved quality of life for patients with severe symptoms, particularly when conventional treatments are inadequate.

Source

Based on findings from:

Scleral Lens Evolution

Carl Kramer, OD. Contact Lens Spectrum, 2026.

https://www.clspectrum.com/issues/2026/may-june/scleral-lens-evolution

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.